MRC LMS

Name

MRC LMS

Legal name

LMS Laboratory of Medical Sciences

Website

https://lms.mrc.ac.uk

Company type

Private

Founded year

1913

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Biomedical research
• Clinical research training
• Genomics research
• PhD programmes
• Discovery science

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain

Revenue model

1. MRC Core Funding: The MRC Laboratory of Medical Sciences is a core-funded institute of the Medical Research Council (MRC), part of UK Research and Innovation (UKRI). This provides the primary institutional funding for operations and research.
2. External Research Grants: Funding from external bodies including Cancer Research UK, British Heart Foundation, Wellcome Trust, NIHR Imperial Biomedical Research Centre, European Research Council, Academy of Medical Sciences, and other grant-making organizations.
3. PhD Program Support: PhD programs offer students a generous, tax-free stipend of £26,500 per year for four years and cover tuition fees and research consumables. Visa costs covered for overseas students.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

MRC LMS is a publicly funded biomedical research institute that conducts discovery science to advance understanding of human health and disease, bridging fundamental biology with translational and clinical research. It operates core research facilities (Bioinformatics, Flow Cytometry, Genomics, MR Imaging, Metabolomics, Microscopy, Proteomics, and others) and offers research training programmes (PhD, Chain Florey clinician scientist, postdoctoral, and graduate pathways) hosted at Imperial College London's Hammersmith campus.

Product overview

MRC Laboratory of Medical Sciences (LMS) is a research institute offering training programmes and research infrastructure rather than commercial products. Its portfolio includes: the Science Technology Graduate Programme for early-career graduates; three PhD Training Programmes (Core, Transdisciplinary, and Team Science); the Chain Florey Clinician Scientist Programme providing structured clinical academic career development; postdoctoral training with various fellowship schemes; and Core Research Facilities providing access to advanced technologies including bioinformatics, genomics, imaging, and proteomics platforms. These offerings are interconnected through the institute's research groups and facilities, enabling discovery science for human health.

Differentiator

Problem solved

Functional benefit

Brands

• Chain Florey Programme: A clinician scientist training programme named in honor of Howard Florey and Ernst Chain, Nobel Prize winners for penicillin development
• Science Technology Graduate Programme

Products and services

• PhD Programme Funded doctoral research training programme at MRC LMS, providing PhD students with mentorship, access to core research facilities, and integration with Imperial College London for advanced biomedical discovery science.
• Chain Florey Clinician Scientist Programme Clinician scientist training programme managed by Aurelie Tromp at MRC LMS, offering funded research fellowships for medical clinicians pursuing research careers.
• Postdoctoral Training Postdoctoral research positions at MRC LMS, providing early-career researchers with project-based research roles, access to core facilities, and mentorship from group heads.
• Graduate Programme Graduate-level research training programme at MRC LMS, offering structured research experience and exposure to the institute's thematic research areas.
• Core Research Facilities Shared core research facilities operated by MRC LMS for institute researchers and collaborators, spanning Bioinformatics, Flow Cytometry, Genomics, MR Imaging, Metabolomics, Microscopy, Proteomics, and related capabilities supporting discovery and translational science.

Quantifiable outcome

• Returned genetic diagnosis to many families with previously unexplained heart disease
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Eleven partnerships are on record, tiered core, secondary and minor.

• SAMURII (Strategic Alliance of MRC-University Research Investments at Imperial)coreStrategic or Co-development Partner · 3 August 2021Joint initiative between LMS and the Institute of Clinical Sciences to support interdisciplinary PhD studentships. Jointly funded by LMS and ICS, the scheme develops new partnerships with focus on innovation across traditional discipline boundaries.
• Imperial College LondoncoreStrategic or Co-development PartnerLMS is part of the Institute of Clinical Sciences within Imperial College London's Faculty of Medicine. PhD students are enrolled through Imperial College, giving access to the Graduate School's resources and training. Students benefit from Imperial's infrastructure while conducting research at LMS facilities.
• Imperial Institute of Chemical BiologysecondaryStrategic or Co-development PartnerCollaborative partner in SAMURII PhD studentships, working with LMS researchers on projects spanning therapeutic resistance in cancer and other interdisciplinary challenges.
• Rosalind Franklin InstitutesecondaryStrategic or Co-development PartnerExternal partner in SAMURII studentships, collaborating on structural investigation of chromatin reprogramming and organization in development research.
• MRC Centre for Environment and HealthsecondaryStrategic or Co-development PartnerPartner in SAMURII studentship programme focusing on measuring heterogeneity of drug uptake at the single-cell level.
• VWR International LimitedminorStrategic or Co-development PartnerIndustrial collaborator with LMS researchers developing microfluidics-mass spectrometry platform for single-cell biomedical challenges.
• UK BiobankcoreStrategic or Co-development PartnerLMS researchers utilize UK Biobank's large-scale biomedical database for research, including cardiac MRI imaging data from almost 50,000 participants for cardiovascular genomics studies.
• ETH ZürichsecondaryStrategic or Co-development PartnerCollaborating institution in companion study published in Nature Cell Biology applying high-resolution genome mapping to human cells.
• Institute of Oncology Research (IOR), Bellinzona, SwitzerlandminorStrategic or Co-development PartnerContributing institution to senescent cell research study published in Nature Cell Biology.
• University of Tübingen (M3 Research Centre), GermanyminorStrategic or Co-development PartnerCollaborating institution contributing to research on exploiting senescent cell vulnerabilities for anticancer therapy.
• Max Planck Institute for Molecular GeneticssecondaryStrategic or Co-development PartnerInternational academic partner collaborating on research including En1 gene regulation studies with Professor Stefan Mundlos.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• European Molecular Biology Laboratory (EMBL): Intergovernmental research organisation for molecular life sciences with comparable core facility infrastructure, training programmes, and translational research portfolio. EMBL-EBI is a direct collaborator on the Vaquerizas lab's epigenomics work.
• The Institute of Cancer Research (ICR): UK research institute focused on cancer biology with strong overlap in molecular biology, structural biology (helicase research), and clinical translation. Operates a similar mix of discovery science and clinical academic training.
• Wellcome Sanger Institute: UK-based genomics and biomedical research institute with strong overlap in genomics, epigenomics, and large-scale data-driven disease research. Similar funding mix (Wellcome + grants) and similar training/PhD offerings.
• Broad Institute of MIT and Harvard: US biomedical and genomic research institute with overlapping focus on cardiovascular genomics (James Ware holds a Visiting Scientist appointment there). Comparable in scale, technology platform depth, and translational genomics ambitions.
• Max Planck Institute for Molecular Genetics: Berlin-based molecular genetics research institute collaborating with LMS on gene regulation studies (Mundlos lab). Comparable in basic discovery science focus, training programmes, and core facility model.
• Babraham Institute: MRC-funded biomedical research institute near Cambridge focused on signalling, epigenetics, and immunology. Operates the same MRC core-funded model with comparable training programmes and facility access.
• MRC Laboratory of Molecular Biology (LMB): Sister MRC institute in Cambridge focused on molecular biology and structural biology research. Operates under identical MRC/UKRI funding model with comparable size, training programmes, and track record of breakthrough discoveries and Nobel-calibre outputs.
• Francis Crick Institute: London-based biomedical discovery science institute with a similar mix of research groups, training programmes, and core technology platforms. Both are major UK biomedical research organisations with overlapping disease focus areas and shared talent pools.
• Cancer Research UK Cambridge Institute: CRUK-funded cancer research institute with overlapping funders (Cancer Research UK also funds LMS via Discovery Programme Awards). Similar model of charity-funded discovery science plus training pipelines.

Broad incumbents

• Imperial College London Faculty of Medicine: LMS's host institution and parent faculty within which it operates. Provides broader graduate training infrastructure and clinical academic pathways that complement LMS's specialised research training.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mrc-laboratory-of-medical-sciences
• Instagraminstagram.com/mrc.lms
• Xx.com/mrc_lms

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MRC LMS